A multimodal, digital community-based intervention was feasible and decreased illness-related distress in treating patients ...

The partnership will enhance the clinic’s ability to provide specialized respiratory care and reinforce its commitment to ...

St. Vincent’s Riverside is now offering a breakthrough treatment for patients diagnosed with chronic pulmonary obstructive ...

The nature of the work puts these doctors at the center of complex ethical issues, especially when it comes to end-of-life ...

Research reveals GLP-1 and SGLT-2 medications may lower COPD exacerbation risk in diabetes, offering new hope for dual ...

People in rural areas are at greater risk of developing chronic obstructive pulmonary disease (COPD) due to a variety of factors. We explain why.

Censoring research on how to deliver treatments to those most in need isn’t just nonsensical; it puts lives at risk and ...

Our program provides pulmonary and critical care medicine training in a collaborative environment, to include a unique blend of clinical training and clinical-and-laboratory-based research. Our goal ...

The adjusted risk for COPD was elevated among adults who identified as regular cigarette smokers before age 15 years, ...

People with type 2 diabetes who take GLP-1 and SGLT-2 medications have a lower risk of having COPD symptom flare-ups than ...

Sodium-glucose cotransporter 2, or SGLT2, inhibitors and glucagon-like peptide-1 receptor agonists lowered the risk for COPD ...